Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $591.38 | 30 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Inari Medical, Inc. | $104.07 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $71.73 | 5 | $0 (2021) |
| Merck Sharp & Dohme LLC | $70.58 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $69.23 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $67.56 | 4 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $52.52 | 3 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $50.26 | 3 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $31.45 | 2 | $0 (2018) |
| PFIZER INC. | $24.98 | 2 | $0 (2024) |
| Lundbeck LLC | $21.57 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $181.02 | 5 | Inari Medical, Inc. ($104.07) |
| 2023 | $32.10 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($32.10) |
| 2021 | $12.37 | 1 | Janssen Pharmaceuticals, Inc ($12.37) |
| 2020 | $38.89 | 2 | Lundbeck LLC ($21.57) |
| 2019 | $131.54 | 8 | E.R. Squibb & Sons, L.L.C. ($33.34) |
| 2018 | $41.84 | 3 | Otsuka America Pharmaceutical, Inc. ($15.98) |
| 2017 | $153.62 | 10 | SANOFI-AVENTIS U.S. LLC ($52.52) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/23/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $104.07 | General |
| Category: VTE | ||||||
| 05/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/09/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/02/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/18/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: DIABETES | ||||||
| 07/29/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/06/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/04/2020 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $21.57 | General |
| Category: NEUROLOGY | ||||||
| 11/01/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $15.78 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 10/24/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.78 | General |
| Category: Cardiovascular | ||||||
| 10/04/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.56 | General |
| Category: Cardiovascular | ||||||
| 09/12/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: DIABETES | ||||||
| 08/06/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/19/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/11/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/21/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/01/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/26/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: NEPHROLOGY | ||||||
| 05/01/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/20/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/09/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: DIABETES | ||||||
| 10/11/2017 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: NEPHROLOGY | ||||||
| 09/13/2017 | SANOFI-AVENTIS U.S. LLC | LANTUS (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: DIABETES | ||||||
| 08/08/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 17 | 111 | $22,533 | $6,707 |
| 2022 | 1 | 19 | 75 | $15,225 | $3,994 |
| 2021 | 6 | 122 | 329 | $78,144 | $22,510 |
| 2020 | 5 | 180 | 348 | $85,388 | $24,733 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 111 | $22,533 | $6,707 | 29.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 75 | $15,225 | $3,994 | 26.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 37 | 193 | $39,179 | $11,097 | 28.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 34 | 34 | $19,482 | $5,567 | 28.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 11 | 61 | $7,198 | $1,903 | 26.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 18 | 18 | $4,644 | $1,548 | 33.3% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 11 | 11 | $4,125 | $1,418 | 34.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 11 | 12 | $3,516 | $977.64 | 27.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 58 | 58 | $33,234 | $9,074 | 27.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 59 | 122 | $24,766 | $7,143 | 28.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 20 | 124 | $14,632 | $3,878 | 26.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 31 | 32 | $8,256 | $2,795 | 33.8% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 12 | 12 | $4,500 | $1,843 | 41.0% |
About Dr. Mary Weitzel, D.O
Dr. Mary Weitzel, D.O is a Internal Medicine healthcare provider based in Pinehurst, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2011. The National Provider Identifier (NPI) number assigned to this provider is 1851687487.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Weitzel, D.O has received a total of $591.38 in payments from pharmaceutical and medical device companies, with $181.02 received in 2024. These payments were reported across 30 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($591.38).
As a Medicare-enrolled provider, Weitzel has provided services to 338 Medicare beneficiaries, totaling 863 services with total Medicare billing of $57,944. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Pinehurst, NC
- Active Since 06/22/2011
- Last Updated 11/10/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1851687487
Products in Payments
- FLOWTRIEVER CATHETER, S (Device) $104.07
- XARELTO (Drug) $71.73
- JARDIANCE (Drug) $69.23
- ENTRESTO (Drug) $67.56
- ELIQUIS (Drug) $64.44
- LANTUS (Drug) $52.52
- DIFICID (Drug) $38.77
- ZERBAXA (Drug) $31.81
- SAMSCA (Drug) $31.45
- NORTHERA (Drug) $21.57
- ANDEXXA (Biological) $15.78
- LifeVest (Device) $11.65
- CHANTIX (Drug) $10.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pinehurst
Michael Soboeiro, Md, MD
Internal Medicine — Payments: $428,147
Sun Moon Kim, M.d, M.D
Internal Medicine — Payments: $32,753
Joan Maradey, Md, MD
Internal Medicine — Payments: $11,388
Brandon Williams, Md, MD
Internal Medicine — Payments: $7,695
Farra Wilson, D.o, D.O
Internal Medicine — Payments: $5,711
Alex Bonnecaze
Internal Medicine — Payments: $4,702